Title Category Credit Event date Cost
Emerging Applications of CAR T-cell Therapy in Cancer
  • Disease management
  • Oncology
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 This activity will explore the most recent advances of this rapidly evolving therapy, including current data on its efficacy, limitations and challenges in the treatment of multiple myeloma and solid tumors. It will provide an overview of currently existing guidelines for CAR T-cell therapy and will describe best practices in determining individuals’ eligibility for this type of therapy, including factors that may affect treatment efficacy and outcomes.
A Closer Look at Novel Treatment Therapies for Acute Myeloid Leukemia
  • Disease management
  • Oncology
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
 $0.00 This activity will discuss these novel agents’ indications, risks, and benefits and will address which patient populations are most likely to benefit from particular agents. In addition, early-phase clinical trials and emerging therapies will be explored.
New Trends in the Management of Asthma and Chronic Obstructive Pulmonary Disease
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
 $0.00 This activity will provide participants with insight into newer approaches that effectively integrate standard interventions into management plans tailored to the individual’s particular symptoms, review the value of pulmonary rehabilitation, and outline the effective evaluation of therapeutic responses.
The Diagnostic Odyssey for Individuals With Rare Diseases: Leukodystrophies
  • Disease management
  • Health equity
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
 $0.00 This activity will explore recent advances in the diagnosis and treatment of leukodystrophies, including current clinical trials. It will also share insights and perspectives from individuals and their family/caregiver(s) and provide strategies to support their well-being.
What Is Trauma-Informed Care and Why Is it Critical in Health Care Today?
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
 $0.00 This panel discussion will identify ways in which HCPs can incorporate the principles of trauma-informed care into their practice. The ACE study and the connection between adverse childhood experiences and trauma will be reviewed. Methods in which health care professionals (HCPs) can interact with individuals while expressing understanding and empathy in trauma-informed ways to promote healing and reduce the risk of retraumatization will also be discussed.
Finding Your Joy in Practice Again
  • Behavioral health
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will help HCPs and leaders learn the signs to look for, how to communicate about such feelings and how to develop organizational and individual strategies to find joy in practice once again.
Non-Alcoholic Fatty Liver Disease
  • Disease management
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
 $0.00 This activity will discuss the prevalence, diagnosis and factors that contribute to the development of non-alcoholic fatty liver disease (NAFLD). Best practices for the treatment of individuals with NAFLD will also be discussed.
Behavioral Health Identification, Treatment and Referral in Primary Care-Part Three: Behavioral Health Treatment for Children and Adolescents
  • Behavioral health
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
 $0.00 During this activity HEDIS measures related to behavioral health treatment for children and adolescents with ADHD will be discussed. This activity shall also review the assessment and treatment of childhood behavioral disturbances with a focus on appropriate antipsychotic medication prescribing. 
Unveiling Bipolar Disorder in the Pediatric Population
  • Behavioral health
  • Pediatrics
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will provide participants with a better understanding of the prevalence, clinical manifestations, and differential diagnoses for bipolar disorder in children and adolescents and will analyze the common childhood presentations of individuals later diagnosed with bipolar disorder as adults. The expert presenter will also review lessons learned in her own experience treating pediatric patients with bipolar disorder to provide insight into the diagnostic and therapeutic processes that can effectively treat this disorder in affected individuals.
Perinatal Behavioral Health With a Focus on Substance Use Disorder
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 Identification and early intervention for pregnant and postpartum women with substance-use disorders (SUD) are critical for optimizing maternal and neonatal health and wellbeing. The risk factors, common barriers to treatment, evidence-based practices around screening and interventions, and the framework for collaborative strategies to support pregnant and postpartum women with SUD will be discussed.

Pages